Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Human skin has multiple layers and functions, with key roles in protection, temperature control, and appearance.

LED therapy may improve skin health and stimulate hair growth.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Some nutrients and antioxidants may improve skin and hair health, but more research is needed to confirm these benefits.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

Keratin hydrogels from human hair show promise for tissue engineering and regenerative medicine.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Acidic sandy clay damages archaeological hair the most, while dry conditions preserve but make it brittle; silicone oil can help keep the hair flexible.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Melatonin directly affects mouse hair follicles and may influence hair growth.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Phototrichogram helps assess hair loss severity.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.